Summary

Introduction to Europe Mass Spectrometry and Chromatography in Diagnostics Market

The Europe mass spectrometry and chromatography in diagnostics market was valued at $224.0 million in 2024 and is expected to reach $503.3 million by 2033, growing at a CAGR of 9.41% between 2024 and 2033. The analytical and life sciences instrumentation sector in Europe relies heavily on the mass spectrometry (MS) and chromatography markets. These technologies propel advancements in pharmaceuticals, environmental monitoring, diagnostics, and food safety, among other fields, by offering sophisticated techniques for the separation, identification, and quantification of chemical and biological substances. Instead of being used separately, mass spectrometry and chromatography are usually incorporated into workflows in diagnostics. For instance, liquid chromatography-mass spectrometry is perfect for complex sample analysis because it combines the mass analysis capability of mass spectrometry with the separation power of liquid chromatography. In clinical settings, where high-throughput analysis of patient samples is crucial for offering thorough insights that guide diagnosis and treatment, this hybrid approach is especially beneficial. Important diagnostic uses for these technologies in Europe include vitamin profiling, hormone profiling, and other tests that require precise separation and analysis of components.

Market Introduction

The growing complexity of patient samples and the growing need for precision diagnostics are driving the rapid evolution of the Europe mass spectrometry and chromatography in diagnostics market. Clinical diagnostics, personalized medicine, and the search for biomarkers all depend on mass spectrometry (MS) and chromatography technologies because they offer advanced techniques for the separation, identification, and quantification of chemical and biological materials.

Because they provide high-throughput, precise, and dependable analysis for complicated clinical samples, hybrid systems like liquid chromatography-mass spectrometry (LC-MS) have become essential to contemporary diagnostic workflows. These technologies are especially useful for analyzing vitamins, metabolites, hormones, and biomarkers, which allows for early disease detection and individualized treatment plans.

Improvements in metabolomics and proteomics are also driving the market since they are facilitating better disease monitoring, screening, and treatment planning. The need for high-performance diagnostic tools is being further stimulated by growing research into biomarker identification and targeted therapies.

Furthermore, the use of mass spectrometry and chromatography in diagnostics is expanding throughout Europe due to regulatory support, enhanced healthcare infrastructure, and the incorporation of AI-driven analytics. The use of these technologies is anticipated to spread across a variety of clinical applications as they become more widely available, propelling the European diagnostics market's ongoing expansion.

Market Segmentation:

Segmentation 1: by Product Type
• Sample Preparation
• Mass Spectrometry and Chromatography

Segmentation 2: by Application Type
• Therapeutic Drug Monitoring
• Vitamins
• Hormones
• Methylmalonic Acid
• Immunosuppressants
• Others

Segmentation 3: by Country
• Germany
• U.K.
• Spain
• Italy
• France
• Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe mass spectrometry and chromatography in diagnostics market has been segmented based on various categories, such as by product type, application type, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe mass spectrometry and chromatography market consists of various public and few private companies. Key players in the Europe mass spectrometry and chromatography in diagnostics market analyzed and profiled in the study involve established players that offer various kinds of products.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Tecan Group Ltd.
• Merck KGaA
• Chromsystems Instruments & Chemicals GmbH
• RECIPE Chemicals + Instruments GmbH
• SENTINEL CH. SpA

ページTOPに戻る

Table of Contents

Executive Summary
Scope and Definition
1 Mass Spectrometry and Chromatography in Diagnostics Market: Industry Outlook
1.1 Market Overview
1.2 Key Trends
1.2.1 Shift toward Utilization of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as Standard Technique in Diagnostics
1.2.2 Utilization of Automated Sample Preparation Technologies
1.3 Opportunity Assessment of Key Trends
1.4 Product Benchmarking
1.5 Regulatory Landscape
1.5.1 Regulatory Framework in Europe
1.5.1.1 Recommendations for Diagnostic Approval
2 Region
2.1 Regional Summary
2.2 Drivers and Restraints
2.3 Europe
2.3.1 Regional Overview
2.3.2 Driving Factors for Market Growth
2.3.3 Factors Challenging the Market
2.3.4 By Product Type
2.3.5 By Application Type
2.3.6 U.K.
2.3.6.1 By Product Type
2.3.6.2 By Application Type
2.3.7 Germany
2.3.7.1 By Product Type
2.3.7.2 By Application Type
2.3.8 France
2.3.8.1 By Product Type
2.3.8.2 By Application Type
2.3.9 Italy
2.3.9.1 By Product Type
2.3.9.2 By Application Type
2.3.10 Spain
2.3.10.1 By Product Type
2.3.10.2 By Application Type
2.3.11 Rest-of-Europe
2.3.11.1 By Product Type
2.3.11.2 By Application Type
3 Mass Spectrometry and Chromatography in Diagnostics Market: Competitive Benchmarking and Company Profile
3.1 Competitive Landscape
3.1.1 Partnerships, Alliances, and Business Expansions
3.1.2 New Offerings
3.1.3 Mergers and Acquisitions
3.1.4 Regulatory Approvals
3.2 Key Strategies and Development
3.3 Company Competition Matrix
3.4 Company Share Analysis
3.5 Company Profiles
3.5.1 Tecan Group Ltd.
3.5.1.1 Overview
3.5.1.2 Top Products
3.5.1.3 Top Competitors
3.5.1.4 Top Customers
3.5.1.5 Key Personnel
3.5.1.6 Analyst View
3.5.2 Merck KGaA
3.5.2.1 Overview
3.5.2.2 Top Products
3.5.2.3 Top Competitors
3.5.2.4 Top Customers
3.5.2.5 Key Personnel
3.5.2.6 Analyst View
3.5.3 Chromsystems Instruments & Chemicals GmbH.
3.5.3.1 Overview
3.5.3.2 Top Products
3.5.3.3 Top Competitors
3.5.3.4 Top Customers
3.5.3.5 Key Personnel
3.5.3.6 Analyst View
3.5.4 RECIPE Chemicals + Instruments GmbH
3.5.4.1 Overview
3.5.4.2 Top Products
3.5.4.3 Top Competitors
3.5.4.4 Top Customers
3.5.4.5 Key Personnel
3.5.4.6 Analyst View
3.5.5 SENTINEL CH. SpA
3.5.5.1 Overview
3.5.5.2 Top Products
3.5.5.3 Top Competitors
3.5.5.4 Top Customers
3.5.5.5 Key Personnel
3.5.5.6 Analyst View
4 Research Methodology
4.1 Data Sources
4.1.1 Primary Data Sources
4.1.2 Secondary Data Sources
4.1.3 Data Triangulation
List of Figures
Figure 1: Europe Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2024, 2028, and 2033
Figure 2: Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023, 2027, and 2033
Figure 3: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023, 2027, and 2033
Figure 4: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application), $Million, 2023, 2027, and 2033
Figure 5: Product Benchmarking (Mass Spectrometry and Chromatography (by Instruments))
Figure 6: EU IVD Regulation
Figure 7: U.K. Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
Figure 8: Germany Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
Figure 9: France Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
Figure 10: Italy Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
Figure 11: Spain Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
Figure 12: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
Figure 13: Partnerships, Alliances, and Business Expansions, January 2015- June 2024
Figure 14: New Offerings, January 2015- June 2024
Figure 15: Mergers and Acquisitions, January 2015- June 2024
Figure 16: New Offerings, January 2015- June 2024
Figure 17: Mass Spectrometry and Chromatography in Diagnostics Market, Company Competition Matrix
Figure 18: Mass Spectrometry and Chromatography in Diagnostics Market, % Share, 2023
Figure 19: Data Triangulation
Figure 20: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Current State and Future Potential of Key Trends in the Europe Mass Spectrometry and Chromatography in Diagnostics Market
Table 3: Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023-2033
Table 4: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
Table 5: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
Table 6: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
Table 7: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
Table 8: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
Table 9: Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
Table 10: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
Table 11: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
Table 12: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
Table 13: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
Table 14: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
Table 15: U.K. Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
Table 16: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
Table 17: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
Table 18: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
Table 19: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
Table 20: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
Table 21: Germany Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
Table 22: France Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
Table 23: France Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
Table 24: France Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
Table 25: France Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
Table 26: France Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
Table 27: France Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
Table 28: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
Table 29: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
Table 30: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
Table 31: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
Table 32: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
Table 33: Italy Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
Table 34: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
Table 35: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
Table 36: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
Table 37: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
Table 38: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
Table 39: Spain Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
Table 40: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
Table 41: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
Table 42: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
Table 43: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
Table 44: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
Table 45: Rest-of-Europe Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
Table 46: Mass Spectrometry and Chromatography in Diagnostics Market, Key Development Analysis, January 2015-June 2024

Press Release